APA

Courcambeck J., Bouzidi M., Perbost R., Jouirou B., Amrani N., Cacoub P., Pèpe G., Sabatier J. & Halfon P. (20070315). Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. : Antiviral therapy.

Chicago

Courcambeck Jérôme, Bouzidi Mourad, Perbost Régis, Jouirou Besma, Amrani Nolwenn, Cacoub Patrice, Pèpe Gérard, Sabatier Jean-Marc and Halfon Philippe. 20070315. Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. : Antiviral therapy.

Harvard

Courcambeck J., Bouzidi M., Perbost R., Jouirou B., Amrani N., Cacoub P., Pèpe G., Sabatier J. and Halfon P. (20070315). Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. : Antiviral therapy.

MLA

Courcambeck Jérôme, Bouzidi Mourad, Perbost Régis, Jouirou Besma, Amrani Nolwenn, Cacoub Patrice, Pèpe Gérard, Sabatier Jean-Marc and Halfon Philippe. Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. : Antiviral therapy. 20070315.